Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Ding, Li, Bailey, Matthew H., Porta-Pardo, Eduard, Thorsson, Vesteinn, Colaprico, Antonio, Bertrand, Denis, Gibbs, David L., Weerasinghe, Amila +751 more·2018·Cell

Cited by (416)

Items 101–200 of 416

  1. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma
    Rui Zhang, Qi Li, Jialu Fu, Zhechuan Jin, Jingbo Su, Jian Zhang, Chen Chen, Zhimin Geng, Dong Zhang · 2021 · BMC Cancer
  2. Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers
    Solip Park, Fran Supek, Ben Lehner · 2021 · Nature Communications
  3. Diet and Exercise in Cancer Metabolism
    Jason W. Locasale · 2022 · Cancer Discovery
  4. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response
    Zhe Hu, Zimeng Wu, Wei Liu, Yan Ning, Jingbo Liu, Wencheng Ding, Junpeng Fan, Shuyan Cai, Qinlan Li, Wenting Li et al. · 2024 · Nature Genetics
  5. Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future Perspectives
    Diane Qiao, Richard C. Wang, Zhixiang Wang · 2025 · Cells
  6. Cell adhesion-related gene somatic mutations are enriched in aggressive papillary thyroid microcarcinomas
    Jianlu Song, Shouxin Wu, Xiaotian Xia, Yu Wang, Youben Fan, Zhili Yang · 2018 · Journal of Translational Medicine
  7. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
    Shengfeng Wang, Jason J. Pitt, Yonglan Zheng, Toshio F. Yoshimatsu, Guimin Gao, Ayodele Sanni, Olayiwola Oluwasola, Mustapha Ajani, Dominic Fitzgerald, Abayomi Odetunde et al. · 2019 · International Journal of Cancer
  8. Genetic determinants of the molecular portraits of epithelial cancers
    Youli Xia, Cheng Fan, Katherine A. Hoadley, Joel S. Parker, Charles M. Perou · 2019 · Nature Communications
  9. Pan‐Cancer landscape of protein activities identifies drivers of signalling dysregulation and patient survival
    Abel Sousa, Aurélien J. F. Dugourd, Danish Memon, Borgþór Pétursson, Evangelia Petsalaki, Julio Sáez-Rodríguez, Pedro Beltrão · 2023 · Molecular Systems Biology
  10. Biophysical simulations and structure-based modeling of residue interaction networks in the tumor suppressor proteins reveal functional role of cancer mutation hotspots in molecular communication
    Gennady M. Verkhivker · 2018 · Biochimica et Biophysica Acta (BBA) - General Subjects
  11. Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer
    Miranda D. Stobbe, Gian Andri Thun, Andrea Diéguez-Docampo, Meritxell Oliva, Justin P. Whalley, Emanuele Raineri, Ivo Glynne Gut · 2019 · PLoS Computational Biology
  12. Gene expression regulations by long noncoding RNAs and their roles in cancer
    Xinhui Du, Wei Hua, Guoxin Qu, Zhichao Tian, Weitao Yao, Qiqing Cai · 2020 · Pathology - Research and Practice
  13. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network
    Eleonora Mammarella, Carlotta Zampieri, Emanuele Panatta, Gerry Melino, Ivano Amelio · 2021 · Biology Direct
  14. Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers
    Mariko Sasaki, Fumiko Chiwaki, Takafumi Kuroda, Masayuki Komatsu, Keisuke Matsusaki, Takashi Kohno, Hiroki Sasaki, Hideaki Ogiwara · 2019 · Biochemical and Biophysical Research Communications
  15. Benchmarking of spatial transcriptomics platforms across six cancer types
    Sergi Cervilla, Daniela Grases, Elena Perez, Francisco X. Real, Eva Musulén, Julieta Aprea, Manel Esteller, Eduard Porta‐Pardo · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Bioelectricity is a universal multifaced signaling cue in living organisms
    Guangjun Zhang, Michael G. Levin · 2025 · Molecular Biology of the Cell
  17. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Tumor Response to Immunotherapy in Solid Tumors
    Rodney J. Hicks, Amir Iravani, Shahneen Kaur Sandhu · 2019 · PET Clinics
  18. Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer
    Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Ping Wu, Zhiyong Liang · 2020 · Frontiers in Oncology
  19. On the gene expression landscape of cancer
    Augusto González, Dario A. Leon, Yasser Perera, Rolando Perez · 2023 · PLoS ONE
  20. USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
    Tanuza Das, Eun‐Young Lee, Hye Jin You, Eunice EunKyeong Kim, Eun Joo Song · 2022 · Cell Death Discovery
  21. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2‐mutant lung cancer
    Mei‐Chun Cai, Minjiang Chen, Pengfei Ma, Jie Wu, Haijiao Lu, Shengzhe Zhang, Jin Liu, Xiaojing Zhao, Guanglei Zhuang, Zhuang Yu et al. · 2018 · International Journal of Cancer
  22. Spatially interacting phosphorylation sites and mutations in cancer
    Kuan‐lin Huang, Adam David Scott, Daniel Cui Zhou, Liang-Bo Wang, Amila Weerasinghe, Abdülkadir Elmas, Ruiyang Liu, Yige Wu, Michael C. Wendl, Matthew A. Wyczalkowski et al. · 2021 · Nature Communications
  23. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
    Xiaobin Zheng, Jing Lin, Jiani Xiong, Yanfang Guan, Bin Lan, Yi Li, Xuan Gao, Zhaodong Fei, Lisha Chen, Lizhu Chen et al. · 2023 · BMC Cancer
  24. Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma
    Ke Liu, Jintao Guo, Kuai Liu, Peiyang Fan, Yuanyuan Zeng, Chaoqun Xu, Jiaxin Zhong, Qiyuan Li, Ying Zhou · 2018 · EBioMedicine
  25. Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes
    Jan Korbecki, Mateusz Bosiacki, Dariusz Chlubek, Irena Baranowska‐Bosiacka · 2023 · International Journal of Molecular Sciences
  26. Disease classification via gene network integrating modules and pathways
    Zhilong Mi, Binghui Guo, Ziqiao Yin, Jiahui Li, Zhiming Zheng · 2019 · Royal Society Open Science
  27. The signaling pathways that mediate the anti-cancer effects of caloric restriction
    Yiyi Lu, Fengxing Tao, Mengtao Zhou, Kai‐Fu Tang · 2019 · Pharmacological Research
  28. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer
    Nannan Liu, Yun Wu, Weipeng Cheng, Yuxuan Wu, Liguo Wang, Liwei Zhuang · 2021 · BMC Cancer
  29. Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer
    Chen Chen, Dan Gao, Jinlong Huo, Rui Qu, Youming Guo, Xiaochi Hu, Libo Luo · 2021 · Scientific Reports
  30. Dissecting single-cell genomes through the clonal organoid technique
    Jeonghwan Youk, Hyun Woo Kwon, Ryul Kim, Young Seok Ju · 2021 · Experimental & Molecular Medicine
  31. A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
    Jun Li, Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou, Zhenlin Ju, Shwetha V. Kumar, Patrick Kwok‐Shing Ng, Han Chen, Michael A. Davies et al. · 2024 · Nature Cancer
  32. Machine Learning Classification and Structure–Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes
    Steve Agajanian, Oluyemi Odeyemi, Nathaniel Bischoff, Simrath Ratra, Gennady M. Verkhivker · 2018 · Journal of Chemical Information and Modeling
  33. Accurate cancer phenotype prediction with AKLIMATE, a stacked kernel learner integrating multimodal genomic data and pathway knowledge
    V. Uzunangelov, Christopher K. Wong, Joshua M. Stuart · 2020 · bioRxiv
  34. Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer
    Diana Azenha, Santiago Hernández-Pérez, Yusé Martín, Marta S. Viegas, Alexandra Martins, María Celeste Lopes, Eric W.‐F. Lam, Raimundo Freire, Teresa Martins · 2020 · Cancers
  35. EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth
    Joshua M. Corbin, Xufen Yu, Jian Jun Jin, Ling Cai, Gang Greg Wang · 2024 · Oncogene
  36. Decoding the functional impact of the cancer genome through protein–protein interactions
    Haian Fu, Xiulei Mo, Andrei A. Ivanov · 2025 · Nature reviews. Cancer
  37. A technical comparison of spatial transcriptomics platforms across six cancer types
    Sergi Cervilla, Daniela Grases Mendoza, Elena Perez, Francisco X. Real, Eva Musulén, Julieta Aprea, Manel Esteller, Eduard Porta‐Pardo · 2026 · Genome biology
  38. Mutations in Structural Genes of the Mitochondrial Complex IV May Influence Breast Cancer
    Ricardo Cunha de Oliveira, Sávio Pinho dos Reis, Giovanna C. Cavalcante · 2023 · Genes
  39. The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution
    Fırat Özçelik, Mehmet Sait Dündar, A. Baki Yildirim, GARY T. M. HENEHAN, Oscar Vicente, José A. Sánchez-Alcázar, Nuriye Gökçe, Duygu T. Yildirim, Nurdeniz Nalbant Bingol, Dijana Plaseska‐Karanfilska et al. · 2024 · Functional & Integrative Genomics
  40. Huddling substates in mice facilitate dynamic changes in body temperature and are modulated by Shank3b and Trpm8 mutation
    Jason G Landen, Morgane Vandendoren, Samantha Killmer, Nicole L. Bedford, Adam C. Nelson · 2024 · Communications Biology
  41. Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing
    Nahed Jalloul, Israel Gomy, Samantha Stokes, Alexander Gusev, Bruce Evan Johnson, Neal Ian Lindeman, Laura E. MacConaill, Shridar Ganesan, Judy Ellen Garber, Hossein Khiabanian · 2021 · JCO Precision Oncology
  42. Long Noncoding RNA SNHG1 Regulates LMNB2 Expression by Sponging miR-326 and Promotes Cancer Growth in Hepatocellular Carcinoma
    Wentao Mu, Lingyu Guo, Yang Liu, Hui Yang, Shanglei Ning, Guoyue Lv · 2021 · Frontiers in Oncology
  43. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients
    Valéria Pereira Ferrer · 2022 · Cancer Genetics
  44. NAGS, CPS1, and SLC25A13 (Citrin) at the Crossroads of Arginine and Pyrimidines Metabolism in Tumor Cells
    Melissa Owusu-Ansah, Nikita Guptan, Dylon Alindogan, Michio Morizono, Ljubica Caldovic · 2023 · International Journal of Molecular Sciences
  45. Neotelomeres and telomere-spanning chromosomal arm fusions in cancer genomes revealed by long-read sequencing
    Kar‐Tong Tan, Michael K. Slevin, Mitchell L. Leibowitz, Max Garrity-Janger, Jidong Shan, Heng Li, Matthew M. Meyerson · 2024 · Cell Genomics
  46. IL10 hypomethylation is associated with the risk of gastric cancer
    Junjian Tang, Ranran Pan, Lele Xu, Qinghua Ma, Xiuru Ying, Jun Zhao, Haibin Zhao, Miao Li, Yue Xu, Shiwei Duan et al. · 2021 · Oncology Letters
  47. Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge
    Emily S. Boja, Živana Težak, Bing Zhang, Pei Wang, Elaine Johanson, Denise Hinton, Henry Rodriguez · 2018 · Nature Medicine
  48. The clinical outcome, pathologic spectrum, and genomic landscape for 454 cases of salivary mucoepidermoid carcinoma
    Xi Wang, Jiaying Bai, Jing Yan, Binbin Li · 2024 · npj Precision Oncology
  49. Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
    Thierry Soussi, Panagiotis Baliakas · 2022 · Frontiers in Oncology
  50. The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
    Adiba Khan, Kirsteen J. Campbell, Ewan R. Cameron, Karen Blyth · 2023 · Cells
  51. Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
    Hongjin Wu, Weiwei Tian, Xiang Tai, Xuanpeng Li, Ziwei Li, Jing Shui, Juehua Yu, Zhihua Wang, Xiaosong Zhu · 2021 · BMC Genomics
  52. Pan-Cancer Analysis of Histone Methyltransferase KMT2D with Potential Implications for Prognosis and Immunotherapy in Human Cancer
    Guangcheng Luo, Guoning Chen, Peijie Chen, Jianwen Zhou · 2022 · Combinatorial Chemistry & High Throughput Screening
  53. Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens
    Yusuke Oku, Federica Madia, Pierre Lau, Martin Paparella, Timothy J. McGovern, Mirjam Luijten, Miriam Naomi Jacobs · 2022 · International Journal of Molecular Sciences
  54. G protein αq exerts expression level-dependent distinct signaling paradigms
    Dinesh Kankanamge, Mithila Tennakoon, Amila Weerasinghe, Luis Cedeño-Rosario, Deborah N. Chadee, Ajith Karunarathne · 2019 · Cellular Signalling
  55. MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations
    Sisheng Liu, Jinpeng Liu, Yanqi Xie, Tingting Zhai, Eugene W. Hinderer, Arnold J. Stromberg, Nathan L. Vanderford, Jill Kolesar, Hunter Moseley, Li Chen et al. · 2020 · Bioinformatics
  56. A community effort to identify and correct mislabeled samples in proteogenomic studies
    Seungyeul Yoo, Zhiao Shi, Bo Wen, Soon Jye Kho, Renke Pan, Hanying Feng, Hong Chen, Anders Carlsson, Patrik Edén, Weiping Ma et al. · 2021 · Patterns
  57. Germline Rare Deleterious Variant Load Alters Cancer Risk, Age of Onset and Tumor Characteristics
    Myvizhi Esai Selvan, Kenan Onel, Sacha Gnjatic, Robert J. Klein, Zeynep Hulya Gumus · 2022 · npj Precision Oncology
  58. Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies
    Arkadiusz Czerwonka, Joanna Kałafut, Matthias Nees · 2023 · Cancers
  59. Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures
    Salvatore Grisanti, Deborah Cosentini, Marta Laganà, Andrea Abate, Elisa Rossini, Sandra Sigala, Alfredo Berruti · 2019 · Current Opinion in Endocrine and Metabolic Research
  60. Bringing the Genomic Revolution to Comparative Oncology: Human and Dog Cancers
    James A. Cahill, Leslie A. Smith, Soumya Gottipati, Tina Salehi Torabi, Kiley S. Graim · 2024 · Annual Review of Biomedical Data Science
  61. Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum
    Priyanka Chakraborty, Emily Chen, Isabelle McMullen, Andrew J. Armstrong, Mohit Kumar Jolly, Jason A. Somarelli · 2021 · Computational and Structural Biotechnology Journal
  62. Functional Genomics for Cancer Research: Applications In Vivo and In Vitro
    Thomas A. O’Loughlin, Luke A. Gilbert · 2018 · Annual Review of Cancer Biology
  63. Aberrant expression of Wnt/β-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumors
    Keiichi Fujiya, Keiichi Ohshima, Yuko Kitagawa, Keiichi Hatakeyama, Takeshi Nagashima, Daisuke Aizawa, Takeshi Sugino, Kenichi Urakami, Ken Yamaguchi, Masanori Terashima · 2020 · European Journal of Surgical Oncology
  64. The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer
    Cor J. Ravensbergen, Matthew P. Kuruc, Meaghan Polack, Stijn Crobach, Hein Putter, Hans A. J. Gelderblom, Devjit Roy, Rob A.�E.�M. Tollenaar, Wilma E. Mesker · 2021 · Cancers
  65. Widespread perturbation of ETS factor binding sites in cancer
    Sebastian Carrasco Pro, H. Hook, D. Bray, D. Berenzy, Devlin C. Moyer, Meimei Yin, A. Labadorf, R. Tewhey, T. Siggers, J. F. Fuxman Bass · 2022 · bioRxiv
  66. TCGAnalyzeR: An Online Pan-Cancer Tool for Integrative Visualization of Molecular and Clinical Data of Cancer Patients for Cohort and Associated Gene Discovery
    Talip Zengin, Başak Abak Masud, Tuğba Önal-Süzek · 2024 · Cancers
  67. Origin of Genome Instability and Determinants of Mutational Landscape in Cancer Cells
    Sonam Mehrotra, Indraneel Mittra · 2020 · Genes
  68. Expression of LHCGR in Pheochromocytomas Unveils an Endocrine Mechanism Connecting Pregnancy and Epinephrine Overproduction
    Antoine-Guy Lopez, Céline Duparc, Sylvie Renouf, Elise Machevin, Vincent Le Guillou, Jean‐Christophe Sabourin, Guillaume Defortescu, Alexandre Buffet, Anne‐Paule Gimenez‐Roqueplo, Christophe Dubessy et al. · 2022 · Hypertension
  69. Cardelino: Integrating whole exomes and single-cell transcriptomes to reveal phenotypic impact of somatic variants
    Davis James McCarthy, Raghd Rostom, Yuanhua Huang, Daniel J. Kunz, Petr Danecek, Marc Jan Bonder, Tzachi Hagai, Wenyi Wang, Daniel J. Gaffney, Benjamin D. Simons et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  70. zDHHC-Mediated S-Palmitoylation in Skin Health and Its Targeting as a Treatment Perspective
    Farah A. Abdulrahman, King A. Benford, Ge Lin, Andrew J. Maroun, Caleb Sammons, Darya N. Shirzad, Harrison Tsai, Vincent L. Van Brunt, Zack W. Jones, Jafet E. Marquez et al. · 2025 · International Journal of Molecular Sciences
  71. Genomic Determinants of Homologous Recombination Deficiency across Human Cancers
    Tao Qing, Xin‐Feng Wang, Tomi Wei Jun, Li Ding, Lajos Pusztai, Kuan‐lin Huang · 2021 · Cancers
  72. Precision Proteogenomics Reveals Pan-Cancer Impact of Germline Variants
    Fernanda Martins Rodrigues, Nadezhda V. Terekhanova, K. Imbach, Karl R. Clauser, Myvizhi Esai Selvan, I. Mendizabal, Yifat Geffen, Y. Akiyama, Myranda Maynard, T. Yaron et al. · 2025 · Cell
  73. Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells
    Marie Boutet, Kenta Nishitani, Nicole Couturier, Piril Erler, Zheng Zhang, Anna Maria Militello, Marcelo Coutinho de Miranda, Emeline Barbieux, Erik Guillen, Jianmei Wu Leavenworth et al. · 2025 · Immunity
  74. Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer
    Lixi Luo, Qun Wei, Chenpu Xu, Minjun Dong, Wenhe Zhao · 2022 · Frontiers in Immunology
  75. The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
    Veronica Villani, Beatrice Casini, Antonio Tanzilli, Mario Lecce, Fabrizio Rasile, Stefano Maria Telera, Andrea Pace, Francesca Piludu, Irene Terrenato, Francesca Rollo et al. · 2023 · Journal of Translational Medicine
  76. Directional allelic imbalance profiling and visualization from multi-sample data with RECUR
    Yasminka A. Jakubek, Francis Anthony San Lucas, Paul A. Scheet · 2018 · Bioinformatics
  77. Aspects fondamentaux du développement tumoral
    Julie Lemaire, Romain Larrue, Michaël Perrais, Christelle Cauffiez, Nicolas Pottier · 2020 · Bulletin du Cancer
  78. Prediction of druggable proteins using machine learning and functional enrichment analysis: a focus on cancer-related proteins and RNA-binding proteins
    Andrés López‐Cortés, Alejandro Cabrera‐Andrade, Carlos Manuel Cruz Segundo, Julián Dorado, Alejandro Pazos, Humberto González‐Díaz, César Paz‐y‐Miño, Yunierkis Pérez‐Castillo, Eduardo Tejera, Cristian Robert Munteanu · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Development and validation of m6A regulators’ prognostic significance for endometrial cancer
    Xuecheng Pang, Xiang Zhang, Yue Huang, Sumin Qian · 2021 · Medicine
  80. Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma
    Zhen Wang, Gangchen Zhou, Rongchuan Cao, Guolin Zhang, Yongxu Zhang, Mingyue Xiao, Longbi Liu, Xuesong Zhang · 2025 · Frontiers in Immunology
  81. The myosin regulatory light chain Myl5 localizes to mitotic spindle poles and is required for proper cell division
    Iván Ramírez, Ankur A. Gholkar, Erick F. Velasquez, Xiao Guo, Bobby Tofig, Robert D. Damoiseaux, Jorge Z. Torres · 2021 · Cytoskeleton
  82. EPIMUTESTR: a nearest neighbor machine learning approach to predict cancer driver genes from the evolutionary action of coding variants
    Saeid Parvandeh, Lawrence A. Donehower, Panagiotis Katsonis, Teng‐Kuei Hsu, Jennifer Kay Asmussen, Kwanghyuk Danny Lee, Olivier Lichtarge · 2022 · Nucleic Acids Research
  83. A Study on the Prediction of Cancer Using Whole-Genome Data and Deep Learning
    Young-Ji Lee, Junhyung Park, Seung-Ho Lee · 2022 · International Journal of Molecular Sciences
  84. MUC17 mutations and methylation are associated with poor prognosis in adult-type diffuse glioma patients
    Gabriel Cardoso Machado, Valéria Pereira Ferrer · 2023 · Journal of the Neurological Sciences
  85. OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine
    Andrés López‐Cortés, César Paz‐y‐Miño, Santiago Xavier Guerrero, Alejandro Cabrera‐Andrade, Stephen J. Barigye, Cristian Robert Munteanu, Humberto González‐Díaz, Alejandro Pazos, Yunierkis Pérez‐Castillo, Eduardo Tejera · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Diet and Cancer Metabolism
    Jason W. Locasale, Marcus DaSilva Goncalves, Maira Di Tano, Guillermo Burgos-Barragan · 2024 · Cold Spring Harbor Perspectives in Medicine
  87. Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
    Isaias Hernández-Verdín, Kadir Caner Akdemir, Daniele Ramazzotti, Giulio Caravagna, Karim Labrèche, Karima Mokhtari, Khê Hoang‐Xuan, Matthieu Peyre, Franck Bielle, Mehdi Touat et al. · 2022 · npj Precision Oncology
  88. Genetic counselling legislation and practice in cancer in EU Member States
    J. Matt McCrary, Els Van Valckenborgh, Hélène Antoine Poirel, Robin De Putter, Jeroen van Rooij, Denis Horgan, Marie‐Luise Dierks, Olga Antonova, Joan Brunet, Adela Chiriță-Emandi et al. · 2024 · European Journal of Public Health
  89. Integration of large-scale multi-omic datasets: A protein-centric view
    Justin Rendleman, Hyungwon Choi, Christine Vogel · 2018 · Current Opinion in Systems Biology
  90. KRAS mutations upregulate Runx1 to promote occurrence of head and neck squamous cell carcinoma
    Miao Deng, Jiaxin Guo, Zihang Ling, Chi Zhang, Lihong He, Zhaona Fan, Bin Cheng, Juan Xia · 2023 · Molecular Carcinogenesis
  91. MCDHGN: heterogeneous network-based cancer driver gene prediction and interpretability analysis
    Lexiang Wang, Jingli Zhou, Xuan Wang, Yadong Wang, Junyi Li · 2024 · Bioinformatics
  92. The DNA methylome of pediatric brain tumors appears shaped by structural variation and predicts survival
    Fengju Chen, Yiqun Zhang, Lanlan Shen, Chad J. Creighton · 2024 · Nature Communications
  93. Non-genomic activation of the AKT-mTOR pathway by the mitochondrial stress response in thyroid cancer
    Woo Kyung Lee, Sun‐Mi Park, Seul Gi Lee, Seonhyang Jeong, Gibbeum Lee, Dongryeol Ryu, Kristina Schoonjans, Johan H. Auwerx, Jandee Lee, Young Suk Jo · 2022 · Oncogene
  94. Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
    Tracey Immanuel, Jixia Li, Taryn N. Green, Anna Y. Bogdanova, Maggie L. Kalev‐Zylinska · 2022 · Frontiers in Oncology
  95. An integrated analysis of the cancer genome atlas data discovers a hierarchical association structure across thirty three cancer types
    Khong-Loon Tiong, Nardnisa Sintupisut, Min-Chin Lin, Chih-Hung Cheng, Andrew Woolston, Chih-Hsu Lin, Mirrian Ho, Yu‐Wei Lin, Sridevi Padakanti, Chen‐Hsiang Yeang · 2022 · PLOS Digital Health
  96. Exploring Histological Similarities Across Cancers From a Deep Learning Perspective
    Ashish Menon, Piyush Kumar Singh, Palakkad Krishnan Unni Vinod, C. V. Jawahar · 2022 · Frontiers in Oncology
  97. A high homologous recombination deficiency score is associated with poor survival and a non-inflamed tumor microenvironment in head and neck squamous cell carcinoma patients
    Yu Chen, Xiaobin Zheng, Jing Lin, Xuan Gao, Jiani Xiong, Jun Liu, Zhaodong Fei, Chuanben Chen · 2022 · Oral Oncology
  98. Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
    Karthikeyan Subbarayan, Chiara Massa, Sandra Leisz, André Steven, Daniel Bethmann, Katharina Biehl, Claudia Wickenhauser, Barbara Seliger · 2022 · OncoImmunology
  99. Synthetic Lethality in Drug Development: The Dawn is Coming
    Shuaishi Gao, Luhua Lai · 2018 · Future Medicinal Chemistry
  100. Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer
    Lauren Folgosa Cooley, Alexander P. Glaser, Joshua J. Meeks · 2020 · Urologic Oncology Seminars and Original Investigations